IMV Revenue and Competitors
Estimated Revenue & Valuation
- IMV's estimated annual revenue is currently $20M per year.
- IMV's estimated revenue per employee is $434,674
- IMV's total funding is $79.6M.
Employee Data
- IMV has 46 Employees.
- IMV grew their employee count by -54% last year.
IMV's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Director, Contracts Administration | Reveal Email/Phone |
2 | Cardiology Research | Reveal Email/Phone |
IMV Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $99.4M | 458 | 40% | N/A | N/A |
#2 | $20.6M | 133 | 22% | N/A | N/A |
#3 | $156.1M | 146 | -70% | $145M | N/A |
#4 | $3.5M | 45 | -25% | $150M | N/A |
#5 | $1.6M | 21 | 0% | $459.5M | N/A |
#6 | $67.3M | 310 | 16% | $180.7M | N/A |
#7 | $8.5M | 55 | -2% | N/A | N/A |
#8 | $256.3M | 1025 | 9% | $168.5M | N/A |
#9 | $2.8M | 18 | -33% | N/A | N/A |
#10 | $9.1M | 59 | -9% | N/A | N/A |
What Is IMV?
IMV Inc. is a clinical stage biopharmaceutical company dedicated to making immunotherapy more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. IMV is pioneering a new class of immunotherapies based on the Company?s proprietary drug delivery platform. This patented technology leverages a novel mechanism of action that enables the reprogramming of immune cells in vivo, which are aimed at generating powerful new synthetic therapeutic capabilities. IMV's lead candidate, DPX-Survivac, is a T cell activating immunotherapy that combines the utility of the platform with a target: survivin. IMV is currently conducting three Phase 2 studies with Incyte and Merck assessing DPX-Survivac as a combination therapy in ovarian cancer and diffuse large B-cell lymphoma. For more information, please connect at: www.imv-inc.com
keywords:N/A
$79.6M
Total Funding
46
Number of Employees
$20M
Revenue (est)
-54%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Dartmouth
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.7M | 46 | -21% | N/A |
#2 | $20M | 51 | -57% | $79.6M |
#3 | $6.6M | 52 | N/A | N/A |
#4 | $7.5M | 57 | -5% | N/A |
#5 | $11.5M | 63 | -11% | $3M |